EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

Effectiveness of the User-Centered “Healthcare CEO” App for Patients With Type 1 Diabetes Transitioning From Adolescence to Early Adulthood: Protocol for a Randomized Controlled Trial

Yueh-Tao Chiang iD, Hsing-Yi Yu iD, Pei-Kwei Tsay iD, Chi-Wen Chen iD, Chi-Wen Chang iD, Chien-Lung Hsu iD, Fu-Sung Lo iD, Philip Moons iD

JMIR Research Protocols · 2025

DOI: 10.2196/59871 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Yueh-Tao Chiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Nursing, College of Medicine, Chang-Gung University, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Mobile Applications, Self Care. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Young patients aged 16 to 25 years with type 1 diabetes (T1D) often encounter challenges related to deteriorating disease control and accelerated complications. Mobile apps have shown promise in enhancing self-care among youth with diabetes. However, inconsistent findings suggest that further evidence is necessary to confirm the effectiveness of app-based interventions.

Objective

This study aims to evaluate the effectiveness of the Healthcare CEO app in patients with T1D transitioning from adolescence to early adulthood.

Methods

A 2 arms, double-blind, randomized controlled trial will be conducted over a 9-month period, with strategies designed to enhance treatment fidelity. The study expects to enroll 96 patients with T1D, aged 16 to 25 years. Participants will be randomly assigned to either the experimental or control group through central randomization. The intervention will be implemented using the Healthcare CEO app, which consists of 11 interfaces. The research will compare differences in disease control outcomes, confidence in self-management, self-care behaviors, emotional distress, quality of life, and specific diabetes-related knowledge between the 2 groups at baseline and 3, 6, and 9 months after intervention. Additionally, changes within the experimental group will be analyzed before and after the intervention.

Results

The study was funded in August 2020. It was originally scheduled from August 2020 to July 2022 but was interrupted by the COVID-19 pandemic after enrolling 38 participants, with preliminary results anticipated for publication by November 2024. Recruitment resumed in August 2023, with findings expected to be finalized by July 2025.

Conclusions

The Healthcare CEO app is a comprehensive solution tailored specifically for individuals with T1D transitioning from adolescence to early adulthood. This innovative app has the potential to improve the quality of care for adolescents with T1D during this critical stage and may serve as valuable evidence in support of app-based intervention strategies. Trial Registration ClinicalTrials.gov NCT05022875; https://www.clinicaltrials.gov/study/NCT05022875 International Registered Report Identifier (IRRID) DERR1-10.2196/59871

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Mobile ApplicationsSelf CareHumansAdolescentYoung AdultAdultQuality of LifeMaleDouble-Blind MethodFemaleRandomized Controlled Trials as TopicSelf-ManagementTransition to Adult Care

Stichwörter der Autor:innen

adolescenceadolescent patientsappdiabetesearly adulthoodmobile healthteenagertransitiontreatment fidelitytype 1 diabetesuser-centered

Autor:innen und Institutionen

  • School of Nursing, College of Medicine, Chang-Gung University, Taoyuan, Taiwan.
  • Division of Pediatric Endocrinology & Genetics, Department of Pediatrics, Chang-Gung Memorial Hospital, Taoyuan, Taiwan.
  • Department of Nursing, New Taipei Municipal Tu-Cheng Hospital, New Taipei, Taiwan.
  • Department of Public Health and Center of Biostatistics, College of Medicine, Chang-Gung University, Taoyuan, Taiwan.
  • College of Nursing, National Yang Ming Chiao Tung University, Taipei,, Taiwan.
  • Department of Information Management, Chang-Gung University, Taoyuan, Taiwan.

ORCID-Profile: Yueh-Tao Chiang, Hsing-Yi Yu, Pei-Kwei Tsay, Chi-Wen Chen, Chi-Wen Chang, Chien-Lung Hsu, Fu-Sung Lo, Philip Moons

Zitieren

APA

Chiang, Y. T., Yu, H. Y., Tsay, P. K., Chen, C. W., Chang, C. W., Hsu, C. L., Lo, F. S., & Moons, P. (2025). Effectiveness of the User-Centered “Healthcare CEO” App for Patients With Type 1 Diabetes Transitioning From Adolescence to Early Adulthood: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/59871

Vancouver

Chiang YT, Yu HY, Tsay PK, Chen CW, Chang CW, Hsu CL, et al. Effectiveness of the User-Centered “Healthcare CEO” App for Patients With Type 1 Diabetes Transitioning From Adolescence to Early Adulthood: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/59871

BibTeX
@article{Chiang2025,
  author = {Chiang, Yueh-Tao and Yu, Hsing-Yi and Tsay, Pei-Kwei and Chen, Chi-Wen and Chang, Chi-Wen and Hsu, Chien-Lung and Lo, Fu-Sung and Moons, Philip},
  title = {Effectiveness of the User-Centered “Healthcare CEO” App for Patients With Type 1 Diabetes Transitioning From Adolescence to Early Adulthood: Protocol for a Randomized Controlled Trial},
  journal = {JMIR Research Protocols},
  year = {2025},
  doi = {10.2196/59871}
}
Kostenlos starten →